Bank Of Montreal Horizon Therapeutics Public LTD CO Transaction History

Bank Of Montreal

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 01, 2023	SELL	$98.98 - $115.74 $103 Million - $120 Million	-1,039,810 Reduced 87.12%	153,685 $17.8 Million
Q2 2023 Aug 02, 2023	BUY	$96.34 - $112.38 $36.1 Million - $42.2 Million	375,221 Added 45.86%	1,193,495 $123 Million
Q1 2023 Jun 13, 2024	BUY	$107.32 - $113.5 $88.4 Million - $93.5 Million	823,397 New	823,397 $89.9 Million
Q4 2022 Feb 01, 2023	SELL	$62.39 - $113.8 $2.59 Million - $4.73 Million	-41,528 Reduced 4.83%	818,274 $93.1 Million
Q3 2022 Nov 10, 2022	BUY	$58.92 - $84.67 $749,698 - $1.08 Million	12,724 Added 1.5%	859,802 $55 Million
Q2 2022 Aug 11, 2022	SELL	$79.4 - $116.36 $9.38 Million - $13.8 Million	-118,175 Reduced 12.24%	847,078 $72.3 Million
Q1 2022 May 12, 2022	SELL	$86.42 - $109.81 $26.5 Million - $33.6 Million	-306,239 Reduced 24.09%	965,253 $102 Million
Q4 2021 Feb 11, 2022	SELL	$98.56 - $119.91 $2.96 Million - $3.6 Million	-30,051 Reduced 2.31%	1,271,492 $138 Million
Q3 2021 Nov 12, 2021	BUY	$91.91 - $110.37 $45 Million - $54 Million	489,075 Added 60.2%	1,301,543 $145 Million
Q2 2021 Aug 12, 2021	BUY	$86.24 - $95.92 $70.1 Million - $77.9 Million	812,468 New	812,468 $77.6 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.